Lewis M. Watkins

Heath Park
Cardiff, WLS CF144XN, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosis.

Non-invasive biomarkers for Neurosarcoidosis: Complement activation as a tool for diagnosis and prognosis.

Journal: Journal of neuroimmunology

Published: January 03, 2026

The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans.

The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans.

Journal: Brain, behavior, and immunity

Published: November 08, 2024

Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis.

Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis.

Journal: Brain pathology (Zurich, Switzerland)

Published: May 24, 2024

The complement system in neurodegenerative diseases.

The complement system in neurodegenerative diseases.

Journal: Clinical science (London, England : 1979)

Published: October 31, 2023

Complement receptor 1 is expressed on brain cells and in the human brain.

Complement receptor 1 is expressed on brain cells and in the human brain.

Journal: Glia

Published: November 11, 2022

Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.

Complement activation and increased anaphylatoxin receptor expression are associated with cortical grey matter lesions and the compartmentalised inflammatory response of multiple sclerosis.

Journal: Frontiers in cellular neuroscience

Published: November 09, 2022

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome.

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome.

Journal: Brain pathology (Zurich, Switzerland)

Published: September 24, 2021

Meningeal inflammation and cortical demyelination in acute multiple sclerosis.

Meningeal inflammation and cortical demyelination in acute multiple sclerosis.

Journal: Annals of neurology

Published: August 20, 2018

Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.

Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 10, 2018

Complement is activated in progressive multiple sclerosis cortical grey matter lesions.

Complement is activated in progressive multiple sclerosis cortical grey matter lesions.

Journal: Journal of neuroinflammation

Published: March 18, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026